Erratum: Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy (Neuropsychopharmacology (2011) 36 (1289-1295) DOI: 10.1038/npp.2011.14)

Joseph I. Friedman, Jean Pierre Lindenmayer, Frances Alcantara, Stephanie Bowler, Mohan Parak, Leonard White, Adel Iskander, Michael Parrella, David N. Adler, Nicholas D. Tsopelas, Wei Yann Tsai, Vladan Novakovick, Philip D. Harvey, Kenneth L. Davis

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)1317
Number of pages1
JournalNeuropsychopharmacology
Volume36
Issue number6
DOIs
StatePublished - May 2011

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Friedman, J. I., Lindenmayer, J. P., Alcantara, F., Bowler, S., Parak, M., White, L., Iskander, A., Parrella, M., Adler, D. N., Tsopelas, N. D., Tsai, W. Y., Novakovick, V., Harvey, P. D., & Davis, K. L. (2011). Erratum: Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy (Neuropsychopharmacology (2011) 36 (1289-1295) DOI: 10.1038/npp.2011.14). Neuropsychopharmacology, 36(6), 1317. https://doi.org/10.1038/npp.2011.46